These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 21464050)

  • 1. Meta-analysis: impact of drug class on adherence to antihypertensives.
    Kronish IM; Woodward M; Sergie Z; Ogedegbe G; Falzon L; Mann DM
    Circulation; 2011 Apr; 123(15):1611-21. PubMed ID: 21464050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.
    Schulz M; Krueger K; Schuessel K; Friedland K; Laufs U; Mueller WE; Ude M
    Int J Cardiol; 2016 Oct; 220():668-76. PubMed ID: 27393848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraclass differences among antihypertensive drugs.
    Feldman RD; Hussain Y; Kuyper LM; McAlister FA; Padwal RS; Tobe SW
    Annu Rev Pharmacol Toxicol; 2015; 55():333-52. PubMed ID: 25251994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sex-specific antihypertensive drug therapy].
    Pühringer P; Gouya G; Reichardt B; Wolzt M
    Wien Med Wochenschr; 2006 Sep; 156(17-18):498-500. PubMed ID: 17041806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
    Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
    Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Pharmacy Refill Data With Chemical Adherence Testing in Assessing Medication Nonadherence in a Safety Net Hospital Setting.
    Osula D; Wu B; Schesing K; Das SR; Moss E; Alvarez K; Clark C; Halm EA; Brown NJ; Vongpatanasin W
    J Am Heart Assoc; 2022 Oct; 11(19):e027099. PubMed ID: 36193931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line treatment of essential hypertension: A real-world analysis across four antihypertensive treatment classes.
    Stapff M; Hilderbrand S
    J Clin Hypertens (Greenwich); 2019 May; 21(5):627-634. PubMed ID: 30980608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis.
    Copland E; Canoy D; Nazarzadeh M; Bidel Z; Ramakrishnan R; Woodward M; Chalmers J; Teo KK; Pepine CJ; Davis BR; Kjeldsen S; Sundström J; Rahimi K;
    Lancet Oncol; 2021 Apr; 22(4):558-570. PubMed ID: 33794209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions.
    Tu K; Anderson LN; Butt DA; Quan H; Hemmelgarn BR; Campbell NR; McAlister FA;
    Can J Cardiol; 2014 Jun; 30(6):647-52. PubMed ID: 24882536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data.
    Lachaine J; Petrella RJ; Merikle E; Ali F
    Can J Cardiol; 2008 Apr; 24(4):269-73. PubMed ID: 18401466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.
    Ah YM; Lee JY; Choi YJ; Kim B; Choi KH; Kong J; Oh JM; Shin WG; Lee HY
    J Korean Med Sci; 2015 Dec; 30(12):1800-6. PubMed ID: 26713055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
    Suchard MA; Schuemie MJ; Krumholz HM; You SC; Chen R; Pratt N; Reich CG; Duke J; Madigan D; Hripcsak G; Ryan PB
    Lancet; 2019 Nov; 394(10211):1816-1826. PubMed ID: 31668726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.
    Klingbeil AU; Schneider M; Martus P; Messerli FH; Schmieder RE
    Am J Med; 2003 Jul; 115(1):41-6. PubMed ID: 12867233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to Antihypertensive Therapy.
    Reddy P; Dupree L
    Am J Ther; 2016; 23(2):e451-73. PubMed ID: 25719531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2018 Aug; 36(8):1637-1647. PubMed ID: 29847487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-Angiotensin System Inhibitors vs Other Antihypertensives in Hypertensive Blacks: A Meta-Analysis.
    Palla M; Ando T; Androulakis E; Telila T; Briasoulis A
    J Clin Hypertens (Greenwich); 2017 Apr; 19(4):344-350. PubMed ID: 27378313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive persistence and drug class.
    Marentette MA; Gerth WC; Billings DK; Zarnke KB
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
    McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
    JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.